Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion type Assertion NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_head.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion description "[The authors' studies demonstrate that TRP-2 could be a useful antigen target for monitoring or developing immunotherapeutic strategies for glioma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_provenance.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion evidence source_evidence_literature NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_provenance.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion SIO_000772 12843792 NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_provenance.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion wasDerivedFrom befree-20150227 NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_provenance.
- NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_assertion wasGeneratedBy ECO_0000203 NP350563.RAVRQWIQd1-aZVw-bG1MZGs6bd57HwDzRYSw9CjjdrMyE130_provenance.